Analystreport

Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Rexahn Pharmaceuticals, Inc.  (REXN) 
Last rexahn pharmaceuticals, inc. earnings: 8/7 06:30 am Check Earnings Report